OneDigital Investment Advisors LLC Increases Position in Kenvue Inc. (NYSE:KVUE)

OneDigital Investment Advisors LLC raised its position in shares of Kenvue Inc. (NYSE:KVUE) by 3.8% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 19,252 shares of the company’s stock after buying an additional 699 shares during the period. OneDigital Investment Advisors LLC’s holdings in Kenvue were worth $411,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the company. Kiley Juergens Wealth Management LLC lifted its stake in Kenvue by 1.9% during the 4th quarter. Kiley Juergens Wealth Management LLC now owns 27,110 shares of the company’s stock worth $579,000 after acquiring an additional 500 shares in the last quarter. Principle Wealth Partners LLC increased its stake in Kenvue by 3.7% during the fourth quarter. Principle Wealth Partners LLC now owns 14,194 shares of the company’s stock worth $303,000 after purchasing an additional 500 shares during the period. White Pine Capital LLC lifted its position in shares of Kenvue by 1.0% during the fourth quarter. White Pine Capital LLC now owns 54,572 shares of the company’s stock worth $1,165,000 after purchasing an additional 542 shares in the last quarter. Deseret Mutual Benefit Administrators boosted its stake in shares of Kenvue by 29.0% in the fourth quarter. Deseret Mutual Benefit Administrators now owns 2,528 shares of the company’s stock valued at $54,000 after purchasing an additional 568 shares during the period. Finally, SRS Capital Advisors Inc. boosted its stake in shares of Kenvue by 67.4% in the fourth quarter. SRS Capital Advisors Inc. now owns 1,418 shares of the company’s stock valued at $30,000 after purchasing an additional 571 shares during the period. 97.64% of the stock is owned by institutional investors and hedge funds.

Kenvue Trading Up 3.0 %

Shares of Kenvue stock opened at $23.42 on Friday. The company has a fifty day simple moving average of $22.91 and a 200-day simple moving average of $22.41. Kenvue Inc. has a 12-month low of $17.67 and a 12-month high of $24.46. The company has a current ratio of 1.00, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. The stock has a market cap of $44.93 billion, a price-to-earnings ratio of 44.19, a PEG ratio of 2.62 and a beta of 1.02.

Kenvue (NYSE:KVUE) last released its quarterly earnings data on Thursday, February 6th. The company reported $0.26 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.26. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. On average, equities analysts forecast that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 28th. Shareholders of record on Wednesday, May 14th will be given a dividend of $0.205 per share. This represents a $0.82 annualized dividend and a yield of 3.50%. The ex-dividend date of this dividend is Wednesday, May 14th. Kenvue’s dividend payout ratio (DPR) is 154.72%.

Analyst Ratings Changes

Several equities analysts have commented on the stock. Canaccord Genuity Group raised their price target on shares of Kenvue from $24.00 to $29.00 and gave the company a “buy” rating in a research report on Wednesday, March 5th. Piper Sandler lifted their target price on Kenvue from $24.00 to $27.00 and gave the company an “overweight” rating in a report on Monday, February 24th. Evercore ISI assumed coverage on Kenvue in a research note on Monday, March 24th. They set an “in-line” rating and a $25.00 target price for the company. UBS Group reduced their price target on Kenvue from $23.00 to $21.00 and set a “neutral” rating on the stock in a research report on Friday, February 7th. Finally, Citigroup boosted their price objective on Kenvue from $21.00 to $22.00 and gave the stock a “neutral” rating in a research report on Monday, April 14th. Eight equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, Kenvue presently has a consensus rating of “Hold” and an average target price of $24.42.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.